Search

Gerresheimer AG

Closed

SectorHealthcare

65.1 -4.62

Overview

Share price change

24h

Current

Min

64.7

Max

68.15

Key metrics

By Trading Economics

Income

11M

38M

Sales

70M

569M

P/E

Sector Avg

22.028

63.778

EPS

1.63

Dividend yield

1.71

Profit margin

6.731

Employees

12,142

EBITDA

16M

117M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+49.53% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.71%

2.39%

Next Earnings

11 kwi 2025

Market Stats

By TradingEconomics

Market Cap

-382M

2.4B

Previous open

69.72

Previous close

65.1

News Sentiment

By Acuity

16%

84%

28 / 386 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Gerresheimer AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

13 maj 2024, 11:16 UTC

Top News

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Gerresheimer AG Forecast

Price Target

By TipRanks

49.53% upside

12 Months Forecast

Average 102.73 EUR  49.53%

High 122.5 EUR

Low 93 EUR

Based on 13 Wall Street analysts offering 12 month price targets forGerresheimer AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

12

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

67.9 / 74.9Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

28 / 386 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.